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We constructed several well-defined mutations in the nonstructural portion of the poliovirus type I (Mahoney
strain) genome by making small insertions in an infectious cDNA clone. The derived viral strains carrying the
mutations exhibited a variety of distinct plaque phenotypes. Thus, we were able to examine genetic
complementation between different pairs of mutants by comparing the yields of progeny virus in mixed and
single infections. Two mutants bearing lesions in the 2A and 3A regions of the genome, which are defective in
the inhibition of host cell translation and the synthesis of viral RNA, respectively, could be rescued efficiently
by genetic complementation; three replication-deficient mutants containing insertions in the 2B, 3D (replicase),
and 3'-untranslated regions could not. Both the 2A and 3A mutants could be rescued by each other and by all
of the other mutants tested. Because yield enhancement was apparent well before the completion of a single
infectious cycle, it is likely that complementation of both mutants involved early diffusion of functional
products. These data provide the first unambiguous evidence that the nonstructural portion of the poliovirus
genome contains multiple complementation groups. The data also suggest that certain nonstructural functions
act only in cis.
There is a long history of genetic study of picornaviruses
by means of temperature-sensitive mutants obtained by
treating infected cells with chemical mutagens (for a review,
see reference 11). These mutants have been thought to cover
the entire genetic map of each virus. In general, however, it
has been difficult to demonstrate significant genetic comple-
mentation between pairs of these mutants by comparing
yields of progeny virus in mixed and single infections (7, 9,
15). A modest but reproducible enhancement of yield at high
temperature has been reported for two such mutants, but
only in mixed infections with a particular partner (1, 9).
There are several possible explanations for the overall lack
of complementation among these mutants. First, it could be
that because the picornavirus genome is translated as a
single polyprotein, defects which affect the structure of one
segment of the polyprotein alter the structure of multiple
viral polypeptides (11). A similar explanation is that multiple
segments of the polyprotein fold together into a complex
before processing, such that substitution of a faulty cleavage
product cannot occur. Even if the various cleavage products
of the polyprotein fold separately, they might associate
rapidly and not freely dissociate. There is substantial evi-
dence that the individual capsid proteins are not released as
independent polypeptides after cleavage from the capsid
precursor (reviewed in reference 22); hence, it would be
predicted that capsid mutants cannot complement each
other. Furthermore, it is also possible that some events in
the viral life cycle occur in isolated structures or compart-
ments, such that there is not free mixing of products trans-
lated from different RNA molecules. An equivalent situation
would be obtained if each newly synthesized polyprotein (or
segments of each polyprotein) binds immediately to the
RNA molecule from which it has been translated and func-
tions in association with that RNA.
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Complementation has also been studied in experiments on
defective interfering particles and phenotypic mixing. The
existence of defective interfering particles containing large
deletions in the capsid region of their genomes and requiring
a source of wild-type capsid proteins for growth (8) implies
that the structural proteins can be provided in trans. This
finding is supported by repeated demonstrations of free
mixing of structural subunits in mixed infections with
serologically distinct enteroviruses (12, 16, 29). In these
cases it is likely that the entire capsid precursor, rather than
individual capsid proteins, was supplied (11). The inability of
investigators to find defective interfering particles with de-
letions outside of the capsid region is consistent with the
suggestion raised by the above complementation experi-
ments that the nonstructural functions act in cis or at least
act effectively in cis during the early phase of the replicative
cycle (17).
Although these genetic experiments have raised a number
of questions about the picornavirus life cycle, the reliability
of the results obtained with the temperature-sensitive mu-
tants is unclear. Specific nucleotide sequence changes have
never been correlated with specific defects in any of the
mutants. It is not at all clear that the phenotype of these
mutants can be attributed to a single lesion. In fact, there is
evidence that at least some of the mutants contain multiple
defects (5, 10, 15). The presence of multiple mutations might
help to explain why, even though many studies have shown
clearly that capsid proteins can be supplied in trans, com-
plementation of a temperature-sensitive mutant which con-
tains structural defects has never been reported.
The construction of an infectious cDNA copy of poliovi-
rus (23) has now made it possible to obtain mutants that can
be precisely defined and then used to determine which viral
functions can be complemented. Moreover, because it is
possible to make different types of specific alterations in the
viral sequence and then to examine the phenotypes of the
resulting mutants, it should be possible to isolate mutants
with a variety of different plaque phenotypes (e.g., temper-
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FIG. 1. Sequence of mutants used in this study. Mutants were
generated by making small insertions at restriction endonuclease
recognition sites of pSV2-polio, a derivative of the mammalian
expression vector pSV2 (19) which contains an infectious type I
(Mahoney strain) poliovirus cDNA insert. The lesions were mapped
by restriction enzyme digestion, and the sequence of a fragment
which contains the mutation was determined by the method of
Maxam and Gilbert (18). The genomic location of each lesion is
shown.
ature sensitive, cold sensitive, host range). Mixed infections
can be performed with phenotypically distinct pairs of mu-
tants, and the progeny can be distinguished by plaque assay.
We obtained poliovirus mutants which display a variety of
phenotypes by making small insertions in the infectious
cDNA. Complementation experiments with these mutants
provide direct evidence that some, though apparently not all,
of the nonstructural functions of the virus can be provided in
trans.
MATERIALS AND METHODS
DNA procedures. The plasmid from which all mutants
were derived, pSV2-polio, was obtained from V. Racaniello.
The cloning procedures used to construct the mutants and
the transfection procedures used to obtain virus have been
described previously (6, 24).
Cells and viruses. CV-1 cells (African green monkey kid-
ney cells) were maintained in Dulbecco modified Eagle
medium supplemented with 10% fetal calf serum (Hazleton).
HeLa cells were grown in suspension in the Joklik modifi-
cation of minimal essential medium supplemented with 7%
horse serum (GIBCO Laboratories).
All of the master virus stocks used (except the 2A-1 stock)
were produced by isolating a single plaque from a pSV2-
polio transfection and expanding it on HeLa cells by con-
ventional means. The 2A-1 stock was obtained as described
in a previous publication (6), in which it was designated
HF121.
Mutant nomenclature. We have adopted a systematic
nomenclature for poliovirus mutants. Mutants are desig-
nated by the ultimate cleavage product or noncoding region
in which their lesion resides (e.g., 2A indicates an alteration
in protein P2-2A, and 3NC indicates a mutation in the
3'-untranslated region) and by an arbitrary cardinal number
(1, 2, 3, 100, etc.). Hence, 2A-1 is a mutant which contains
a mutation in the region of the genome which codes for
protein 2A and which has been assigned the number 1. In
publications in which mutants from other laboratories are
used, we will use the prefix B for our mutants; when mutants
of different strains of poliovirus are used we will affix a 1 (for
type 1) before the laboratory designation. The full name of
2A-1 will then be 1B-2A-1.
Virus infections and measurement of progeny virus yields.
CV-1 infections were performed in 60-mm (diameter) petri
dishes as previously described (6), except that after adsorp-
tion cells were washed three times to remove excess virus.
HeLa cell infections were also performed as previously
described (6), but after adsorption cells were collected by
centrifugation and washed. The incubation temperature after
adsorption was that at which the growth of all mutants was
restricted.
At various times after infection, we harvested cells to
measure the yield of progeny virus. CV-1 cells were placed
on ice, scraped into the medium with a rubber policeman,
and then frozen. A portion of each infected HeLa cell culture
(100 ,ul containing 3 x 105 cells) was added to 1 ml of cold
minimal essential medium and then frozen. These samples
were subjected to three freeze-thaw cycles, and dilutions
were prepared so that virus titers could be determined by
plaque assay.
The complementation index (CI) was defined as follows.
For plaque size mutants (i.e., 2A-1, 2B-201, and 3D-3), CI
for mutant A = (titer of mutant A in mixed infection)/(titer of
mutant A in single infection), where the titers are measured
at the same temperature. For temperature-dependent mu-
tants (i.e., 3A-1 and 3NC-202), CI for mutant A = (titer of
mutant A in mixed infection)/(virus yield in single infection
at permissive temperature - yield at nonpermissive temper-
ature), where the titer of mutant A in the mixed infection is
determined by counting plaques arising at the temperature
which is permissive for the growth of that mutant. Because
the background of apparent revertants (i.e., variants which
grew at all temperatures) often represented a very significant
fraction of the total virus obtained in single infections, it was
necessary to subtract this value from the denominator to
assess the level of complementation accurately.
RESULTS
Description of mutants used in this study. Three of the
mutants used in this study, 2A-1 (formerly designated
HF121), 3A-2, and 3D-3, were generated by a method which
has been described previously (6), in which Hinfl sites in the
plasmid pSV2-polio were filled in with DNA polymerase to
create single-codon insertions. By restriction digest analysis,
the mutations were found to reside in regions which encode
the 2A, 3A, and Pol (3D) portions of the polyprotein,
respectively (see Fig. 1). The other two mutants were
constructed by insertion of synthetic DNA linkers into
restriction sites. Mutant 2B-201 was generated by lineariza-
tion of pSV2-polio by partial digestion with the restriction
endonuclease HincII and subsequent ligation of synthetic
HpaI linkers containing the sequence GTTAAC. This mu-
tant contains two extra amino acids in the 2B region of the
polyprotein (see Fig. 1). The construction of 3NC-202 (for-
merly designated PTH7387), a mutant which contains a
lesion in the 3'-untranslated region, has been described
previously in detail (24). Briefly, a TaqI site was filled in with
DNA polymerase, and HpaI linkers were attached to create
a net insertion of eight base pairs (Fig. 1). To show that the
insertion, rather than an accidental second alteration in the
DNA, was responsible for the phenotype of each mutant, we
exchanged a restriction fragment of mutant DNA which
contained the insertion with the equivalent wild-type frag-
ment. We then showed that only those clones which con-
tained the insertion gave rise to the mutant phenotype. In
addition, we checked the nucleotide sequence of the mutant
restriction fragment and showed that the only alteration was
the insertion (data not shown).
Each of the mutants used in these experiments has a
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ties (Table 1). Mutant 2A-1 has been described previously in
detail (6). This mutant makes minute plaques at all temper-
atures on monolayers of m'onkey kidney (CV-1) and HeLa
cells. The plaques are so small that they can not be clearly
visualized until the day following that on which wild-type
and other mutant plaques are ordinarily scored. Mutant 2A-1
lacks the ability to mediate the selective inhibition of host
cell translation which normally occurs in the first few hours
after infection. An apparent consequence of this defect is the
synthesis of only a very small amount of viral protein.
Although enough protein is made in CV-1 cells to allow a
normal course ofRNA synthesis, the production of progeny
virus is very low. In HeLa cells, where less viral RNA is
made, the production of progeny virus is even lower.
Mutant 2B-201 produces small plaques at all temperatures
on both HeLa and CV-1 cells. Although the plaques are
considerably smaller than those produced by wild-type vi-
rus, if scored at times after wild-type plaques have reached
a moderate size, they ordinarily increase only in size and not
in number. This mutant produces only about 10% as much
RNA as wild-type virus. Viral protein synthesis is reduced to
approximately the same extent as viral RNA synthesis, but
the cleavage of the polyprotein appears to be normal. In
addition, the number of infectious particles produced in a
single cycle of infection is reduced about 10-fold (Sarnow
and Baltimore, unpublished data).
Mutant 3A-2 contains an insertion in a region of the
polyprotein which has been proposed to have a role in the
initiation of poliovirus RNA synthesis (4, 26). This mutant is
cold sensitive in monkey kidney cells. Nearly wild-type size
plaques are produced at 39.5°C, whereas only small plaques,
reduced in number at least 100-fold, are made at 32.5°C. At
the nonpermissive temperature, RNA synthesis is poor. As
expected, very little protein is synthesized, and the yield of
particles in a single cycle of infection is at least several
TABLE 1. Phenotypes of mutants used in this study
Mutant Plaque Description of phenotype
designation phenotype
2A-1 Minute plaque At all temperatures, mutant plaques
clearly visible only 1 day after all
other plaques scored
2B-201 Small plaque At all temperatures, mutant plaques
much smaller than wild-type
plaques but scored at same time
3A-2 Cold sensitive At 39.5°C, mutant plaques some-
what smaller than wild-type
plaques; at 32.5°C, >100-fold
reduction in number of plaquesa
3D-3 Small plaqueb At all temperatures, mutant plaques
somewhat smaller than wild-type
plaques
3D-3ts Temperature- At 32.5°C, mutant plaques some-
sensitive what smaller than wild-type
variant of plaques; at 39.5°C, up to fivefold
3D-3 reduction in number of plaques-
mutant plaques much smaller
than wild-type plaques but scored
at same time
3NC-202 Temperature At 32.5°C, mutant plaques some-
sensitive what smaller than wild-type
plaques; at 39.5°C, >1,000-fold
reduction in number of plaques
a Observed on monkey kidney cells; cold sensitivity was much less marked
on HeLa cells.






FIG. 2. Distinction of mutants by plaque phenotype. HeLa cells
were infected at an MOI of 5 with wild-type virus, 2B-201, 2A-1, or
a mixture of the two mutants, each at an MOI of 5, and incubated at
37°C. Titers of virus stocks made from infected cells were deter-
mined by plaque assay at the same temperature. Duplicate dishes of
HeLa cells were stained approximately 40 h (day 2) or 65 h (day 3)
after inoculation with virus. (A) 2B-201, day 2; (B) 2B-201, day 3;
(C) 2A-1, day 2; (D) 2A-1, day 3; (E) mixed, day 2; (F) mixed, day
3; (G) wild type, day 2. The mixed stock contained primarily 2A-1
virus, as indicated by the appearance of most of the plaques on day
3 and as confirmed by analysis of the phenotype of the virus
contained in the plaques. (The plaques in C were apparent
revertants.)
hundredfold below the wild-type level (Bernstein and Balti-
more, unpublished data).
Mutant 3D-3 produce plaques which are somewhat smaller
than wild-type plaques at all temperatures on CV-1 cell
monolayers. In cells infected by this mutant, viral RNA
synthesis reaches normal levels but is somewhat delayed.
(At 39.5°C, only about one-third to one-half as much RNA is
made, but this result may be due to activation of a nuclease
at high temperature at a time after wild-type RNA synthesis
is complete [13].) Protein synthesis and particle formation
appear to be normal, but because of the delay in RNA
synthesis the number of virions produced by the middle of an
infectious cycle can be as much as 100-fold below the
wild-type level. In some experiments, we used a tempera-
ture-sensitive variant of 3D-3 (3D-3ts) which arose sponta-
J. VIROL.
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FIG. 3. Pattern of protein synthesis in singly and doubly infected
CV-1 cells at 32.5°C. CV-1 cells were infected at an MOI of 10 with
a single virus strain or with a mixture of 2A-1 and 3A-2, each at an
MOI of 10. At 5 h postinfection, cells were pulse-labeled for 25 min
with [35S]methionine. Labeling, preparation of cell extracts, and
analysis of proteins by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis were performed essentially as described previously
(6). Lanes: 1, mock-infected cells; 2, 2A-1-infected cells; 3, 3A-2-
infected cells; 4, cells doubly infected with 2A-1 and 3A-1 (MIX); 5,
wild-type (WT)-infected cells.
neously during the production of a 3D-3 stock. This variant
has the same physiology as its parent, except that at high
temperatures a second (apparently unrelated) lesion affects
the production of infectious particles and consequently the
size and number of plaques.
Mutant 3NC-202 is a highly temperature-sensitive mutant
on all cell types; it produces almost no RNA and 10-3 to 10-4
of the wild-type yield of infectious particles in a single cycle
of infection at 39.5°C (24). Most of the plaques generated by
this mutant at the nonpermissive temperature are apparent
revertants (presumably generated by second-site mutations).
Some of the normal cleavages of the polyprotein are not
made because of the inability of the virus to replicate and
because of the reduction in the level of virally encoded
proteases (Sarnow and Baltimore, manuscript in prepara-
tion).
The number of wild-type viral particles produced in a
single cycle of infection was not significantly reduced when
CV-1 cells were coinfected with wild-type virus and 2A-1,
3A-2, or 3D-3, even if eight times more mutant than wild-
type virus was added. In addition, a wild-type, and not a
mutant, level of viral RNA was produced in HeLa cells
infected with equal amounts of wild-type and 2A-1 virus
(data not shown). These results indicate that the lesions in
these three mutants are not dominant.
Detection of genetic complementation between mutants. In
the experiments described here, the principal assay for the
rescue of one mutant by another depends on the ability to
distinguish plaques of the two mutants. The distinctive
plaque phenotypes of the mutants which we constructed
enabled us to perform mixed infections of two types. First,
we could doubly infect cells with mutants which produce
plaques of clearly different sizes. Second, we could infect
cells with a mutant which grows well only at one tempera-
ture along with another which has a defined plaque size at all
temperatures. An example of results obtained from the first
type of experiment is shown in Fig. 2. On HeLa cell
monolayers, plaques of mutant 2B-201 appeared on day 2
after infection (Fig. 2A; compare with the wild type in 2G)
and increased in size (but not number) by day 3 (Fig. 2B).
With the exception of variants of the mutant which behaved
like wild-type virus (here designated revertants, although
they are probably the result of second-site mutations), 2A-1
plaques were not visible on day 2 but became apparent only
on day 3 (Fig. 2C and D). Examination of the progeny of a
mixed infection with the two mutants showed that the titer of
virus yielding visible plaques on day 2 was not greater than
that produced in the 2B-201 infection (Fig. 2E; the virus
dilution was 4-fold greater than in 2A), but approximately
60-fold more virus yielding plaques on day 3 was produced
than in the 2A-1 infection (Fig. 2F; the virus dilution was
40-fold greater than in 2D). We confirmed that most of the
plaques produced by mixed stocks which appeared on day 2
were 2B-201 plaques, whereas most that appeared on day 3





















FIG. 4. Complementation test between mutants 2A-1 and
2B-201. Virus titers of stocks made at 3.5, 4.5, and 5.5 h postinfec-
tion in the experiment described in the legend to Fig. 2 are shown.
We determined the 2B-201 titer in the mixed stock by counting
plaques which appeared on day 2 after inoculation and measured the
2A-1 titer by counting only the minute plaques which appeared on
day 3. The titer of 2B-201 virus in the 3.5-h mixed stock could not be
accurately determined because of the background created by the
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TABLE 2. Complementation tests between mutants 3A-2 and 2A-1, 3D-3ts, or 2B-201a
Titer in PFU/cell (CI)b
Virus stock 6 h postinfection 8 h postinfection Plaque type
39.5°C 32.5°C 39.50C 32.5°C
Expt 1
Wild type 35 40 220 260 Wild type
3A-2 0.071 0.012 0.87 0.57 3A-2 + variants (39.50C); variants (32.5°C)
(<wild type)c
2A-1 0.34 0.14 3.0 1.5 2A-1 (minute)d
3A-2 + 2A-1 3.2 (54) 19 (63) 3A-2 (<wild type)
9.0 (64) 78 (52) 2A-1 (minute)
3D-3ts 1.4 4.8 26 100 3D-3ts (smalle [39.50C]; <wild type [32.50C])
3A-2 + 3D-3ts 2.4 (41) 23 (77) 3A-2 (<wild type)
4.5 62 3D-3ts (<wild type)
Expt 2
Wild type 34 29 150f 150f Wild type
3A-2 0.090 0.046 0.88f 0.60f 3A-2 and variants (<wild type)
2A-1 0.29 0.12 1.8f 0.82f 2A-1 (minute)
3A-2 + 2A-1 3.6 (82) 15 (54/ 3A-2 (<wild type)
7.5 (63) 34 (41/ 2A-1 (minute)
2B-201 0.10 0.096 5.8f 4.7f 2B-201 (small)
3A-2 + 2B-201 0.68 (15) 6.4 (23) 3A-2 (<wild type)
0.36 (3.8) 5.0 (1.1f 2B-201 (small)
a CV-1 cells were infected with wild-type virus or a mutant at an MOI of 5 or with a mixture of two mutants, each at an MOI of 5, and then incubated at 32.50C.
Cells were harvested at various times after infection, and virus stocks were made as described in Materials and Methods.
b The CI values (shown in parentheses) were calculated as described in Materials and Methods.
c Intermediate-size plaques which were somewhat smaller than those produced by wild-type virus.
d Extremely small plaques which were clearly visible only 1 day after all others were scored.
e Plaques much smaller than those of wild-type virus but scored at the same time as wild-type plaques.
f At 7.5 h postinfection.
tained in the plaques was replated on a fresh monolayer, it
had the expected mutant phenotype (data not shown). More-
over, because no more than 2 to 3% of the total virus
produced in the mixed infection in this and all other exper-
iments described here was phenotypically wild-type virus
(i.e., revertant or recombinant virus), it was clear that
recombination between mutants did not significantly contrib-
ute to virus yield.
Rescue of one mutant by another, as measured by en-
hancement of virus yield, was strongly correlated with
physiological differences between singly and doubly infected
cells. Under conditions in which the mutants described here
grew poorly, induction of the dramatic morphological
changes in adherent cells which normally precede cell death
(the cytopathic effect) was greatly delayed. When either one
or both mutants in a mixed infection were rescued, the
cytopathic effect proceeded at a rate which was similar to
that seen after infection with wild-type virus. Rescue of
mutants also correlated with changes in the pattern of
macromolecular biosynthesis. An example is shown in Fig.
3, which illustrates protein synthesis in infected CV-1 cells at
the onset of the linear phase of RNA replication. Because
mutant 2A-1 failed to inhibit host cell translation, the pattern
of proteins produced 5 h postinfection at 32.5°C was very
similar to that seen in mock-infected cells (Fig. 3, lanes 1 and
2). Mutant 3A-2, on the other hand, produced very little viral
protein because it synthesized RNA poorly at this tempera-
ture; nevertheless sufficient protein was made to effect
inhibition of host cell translation (Fig. 3, lane 3). When cells
were infected with the two mutants together, however, the
pattern of protein synthesis was very similar to that ob-
served in wild-type-infected cells (Fig. 3, compare lanes 4
and 5). Host cell translation was inhibited, and a high level of
virus-specific protein was produced. It should be empha-
sized that although these physiological changes correlated
with virus rescue, they gave no indication as to which
mutant had been rescued.
Rescue of mutant 2A-1 by other cDNA-derived mutants. By
taking advantage of the observation that 2A-1 plaques ap-
pear unusually late after infection and that the virus grows at
all temperatures, whereas some other mutants do not, we
found that the titer of mutant 2A-1 increased dramatically
when either HeLa or CV-1 cells were coinfected with any
other cDNA-derived mutant. Figure 4 shows the complete
data of the experiment from which the results displayed in
Fig. 2 were taken. HeLa cells were infected with wild-type
virus, 2A-1, 2B-201, or a mixture of the two mutants. The
titer of 2A-1 stocks made at different times after infection
was several hundredfold below that of wild-type virus. In a
mixed infection with 2B-201, however, an increase in titer of
50- to 100-fold was apparent both at midcycle (3.5 h postin-
fection), when significant accumulation of progeny virions is
first observed (3), and toward the end of the infectious cycle
(4.5 and 5.5 h postinfection). In addition, the level of
apparent revertants of 2A-1 was substantially reduced in
stocks made from the mixed infection (data not shown). The
five- to sevenfold-lower titer of 2A-1 in the mixed infection
compared with that of wild-type virus was probably in part
an experimental artifact. The slightly lower particlelPFU
ratio often found for 2A-1 stocks plated on HeLa cells (data
not shown) suggested that plaque assays on this cell line
gave an underestimate of the virus titer because of the
relative inability of the mutant to form visible plaques.
Mutant 2A-1 could also be complemented by the cold-
sensitive mutant 3A-2 (Table 2, experiment 1). CV-1 cells
were infected with wild-type virus, 2A-1, 3A-2, or an equal
mixture of the two mutants and then incubated at 32.5°C.
Virus stocks were made both at midcycle (6 h postinfection)
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TABLE 3. Complementation tests among mutants 2A-1, 3D-3, and 3NC-202a
Titer in PFU/cell (CI)b
Virus stock 3.25 h postinfection 4.75 h postinfection Plaque type
39.5°C 32.5°C 39.5°C 32.5°C
Expt 1
Wild type 60 63 300 330 Wild type
3NC-202 <0.0003 0.006 0.0075 0.098 Variants (39.5°C) (mixed)c; 3NC-202 + variants
(32.50C) (<wild type)d
2A-1 0.13 3.5 2A-1 (minute)e
3NC-202 + 2A-1 9.5 (73) 74 (21) 2A-1 (minute)
Expt 2
Wild type 74f Wild type
3NC-202 0.0028f 0.020f Variants (39.5°C) (mixed); 3NC-202 + variants
(32.5°C) (<wild type)
2A-1 0.054f 2A-1 (minute)
3NC-202 + 2A-1 8.8 (160) £ 2A-1 (minute)
3D-3 2.4" 3D-3 (<wild type)
3D-3 (day 3)h 2.3f 3D-3 (<wild type)
3NC-202 + 3D-3 5.8 (2.4)f 7.5f 3D-3 (<wild type)
2A-1 + 3D-3 5.0 (2.1)f 3D-3 (<wild type)
8.3 (150)f 2A-1 (minute)
a CV-1 cells were infected with wild-type virus or a mutant at an MOI of 5 or with a mixture of mutants, each at an MOI of 5, and then incubated at 39.5'C.
Cells were harvested at various times after infection, and virus stocks were made as described in Materials and Methods.
I The CI values (shown in parentheses) were calculated as described in Materials and Methods.
c Plaques of mixed size, ranging from very small to wild-type size.
d Intermediate-size plaques which were somewhat smaller than those produced by wild-type virus.
e Extremely small plaques which were clearly visible only 1 day after all others were scored.
f At 3 h postinfection.
g
-, 3NC-202 titer could not be calculated. The mutant titer must have been small compared with the background of recombinant and revertant plaques because
there was no significant increase in the number of relatively large plaques which appeared at 32.5'C.
h Plaques counted 1 day later than usual, at the same time that minute plaques were scored.
and late after infection (8 h). The 2A-1 titer in the 2A-1 and
mixed stocks was scored by allowing plaques to develop for
4 days at 32.5°C. In the mixed stock, virtually no plaques
appeared before 4 days because 3A-2 produces very few
plaques at 32.5°C and evidently also because very few
apparent revertants of either mutant arose during the mixed
infection. Calculation of the CI revealed that at both time
points the titer of 2A-1 was increased 50- to 70-fold in the
mixed infection, such that the number of infectious particles
was only a fewfold below that produced in a wild-type
infection. Titration of the 2A-1 stock at 39.5°C, however,
revealed a twofold cold sensitivity of the mutant (Table 2).
This observation suggested that the amount of 2A-1 virus
produced in the mixed infection may have been even closer
to the wild-type level than was evident by measurement of
the titer at low temperature. (A second experiment which
yielded very similar results is shown in Table 2, experiment
2.)
We also assessed the ability of the temperature-sensitive
mutant 3NC-202 to complement 2A-1 in experiments per-
formed at 39.5°C. CV-1 cells were infected with wild-type
virus, 2A-1i 3NC-202, or an equal mixture of the two
mutants (Table 3, experiment 1). Virus stocks were made at
midcycle (3.25 h postinfection) and late after infection (4.75
h). At 39.5°C the mixed stock yielded primarily 2A-1 plaques
which could be visualized on day 3. A small number of
plaques appeared on day 2, but these were all of wild-type
size and contained virus which had a wild-type phenotype;
the same number of such plaques arose if the plaque assay
was performed at 32.5°C. These plaques were apparently
generated by either revertant or recombinant viruses. At the
early time point, coinfection with both 2A-1 and 3NC-202
enhanced the titer of 2A-1 progeny about 70-fold. At 4.75 h,
the increase was about 20-fold, but the reduction in enhance-
ment was a consequence of the difference in growth kinetics
in the 2A-1 and mixed infections. Whereas production of
progeny tapered off between the two time points in the
mixed infection (as in the wild-type infection), the increase
in new virus in cells infected with 2A-1 alone was more
marked. It was clear, however, that in a mixed infection
3NC-202 could increase the burst size of 2A-1 by the end of
a cycle of infection to a level only a fewfold lower than that
of wild-type virus.
In another experiment performed at 39.5°C, it was possi-
ble to demonstrate that 3D-3 also complemented 2A-1.
Because the linear phase ofRNA synthesis and the concom-
itant assembly of most of the progeny virions are delayed in
3D-3-infected cells, there is a short period during which
3D-3-infected cells contain 30- to 100-fold fewer infectious
particles than wild-type cells. To perform complementation
experiments with 3D-3, it was necessary to harvest cells
during this period. Infected CV-1 cells were harvested at 3 h
(Table 3, experiment 2). Both 2A-1 and 3D-3 grew at this
temperature but, by the time 2A-1 plaques were observable,
3D-3 plaques were relatively large and could be easily
distinguished. The titer of minute (2A-1) plaques in the
mixed stock was over 100-fold greater than that found in the
2A-1 stock. 3D-3 rescued 2A-1 to approximately the same
extent as 3NC-202 did in the same experiment. In both
mixed stocks, the 2A-1 titer was eight- to ninefold lower than
the wild-type titer but, given the potential differences in
growth curves, this number might have been reduced if a
later time point could have been taken.
Rescue of mutant 3A-2 by other cDNA-derived mutants.
The distinctive cold sensitivity of 3A-2 enabled us to dem-
onstrate its rescue by genetic complementation. In the
experiments in which it was possible to test the ability of
3A-2 to complement 2A-1 by determining the titers of mixed
1045VOL. 60, 1986
1046 BERNSTEIN ET AL.
TABLE 4. Complementation test between mutants 3NC-202 and 2B-201a
Titer in PFU/cell (CI)b
Virus stock 3 h postinfection 4 h postinfection 5 h postinfection Plaque type
39.50C 32.5°C 39.5°C 32.50C 39.50C 32.50C
Wild type 57 53 230 240 410 340 Wild type
3NC-202 <10-4 0.0053 0.0046 0.013 0.0070 0.022 Variants (39.5°C) (mixed)c; 3NC-202 + variants
(32.50C) (<wild-type)'
2B-201 0.017 0.013 2.7 2.4 28 26 2B-201 (small)e
3NC-202 + 2B-201 .f f 5.8 (2.1) 7.8 49 (1.8) 41 2B-201 (small)
a HeLa cells were infected with wild-type virus or a mutant at an MOI of 5 or with a mixture of the two mutants, each at an MOI of 5, and then incubated at
39.5'C. Cells were harvested at 3, 4, and 5 h after infection, and virus stocks were prepared as described in Materials and Methods.
bThe CI values (shown in parentheses) were calculated as described in Materials and Methods.
c Plaques of mixed size, ranging from very small to wild-type size.
I Intermediate-size plaques which were somewhat smaller than those produced by wild-type virus.
ePlaques much smaller than those of wild-type virus but scored at the same time as wild-type plaques.
f
-, The titers of both mutants were relatively small compared with the background of revertants and recombinants.
stocks generated at low temperature at 32.5°C, we were also
able to determine whether 2A-1 could complement 3A-2 by
determining the titers of the same stocks at 39.5°C (Table 2,
experiment 1). At low temperature, 3A-2 grew poorly and
the virus population in the 3A-2 stocks was composed
largely of apparent revertants. Calculation of the CI indi-
cated a greater than 50-fold increase in the 3A-2 titer in
mixed stocks prepared at both 6 and 8 h postinfection. The
relatively large plaques which appeared at high temperature
did not appear at the lower temperature and contained
cold-sensitive virus; hence, it could be concluded that they
were produced by 3A-2 particles and not by revertants or
recombinants. Even after rescue by genetic complementa-
tion, however, the titer of 3A-2 was 10-fold lower than that
of wild-type virus and a fewfold lower than that of the
mutant it had rescued (2A-1). (A second experiment which
yielded very similar results is shown in Table 2, experiment
2.)
It was of interest to determine whether 3A-2 could also be
complemented by other mutants. In principle, analogous
experiments can be performed with the other small-plaque
mutants described above. Attempts to assess the ability of
3D-3 to rescue 3A-2 by using only the methods outlined here,
however, were hampered by a combination of two diffi-
culties. First, the plaques produced by 3A-2 and 3D-3 at
39.5°C were not distinguishable by inspection. Second, the
titers of mixed stocks at 39.5°C were only a fewfold higher
than those of 3D-3 stocks, even if the cells were harvested
relatively early after infection (data not shown). Such a
result did not exclude a substantial rescue of 3A-2. To
circumvent the problem of distinguishing plaques produced
by the two mutants, we performed complementation exper-
iments with a temperature-sensitive variant of 3D-3 (3D-3ts).
Stocks of 3D-3ts yielded fewer plaques at 39.5°C than at
32.5°C, and the relatively tiny plaques which were produced
could be distinguished from those made by 3A-2 (though,
unlike 2A-1 plaques, 3D-3ts plaques were visible when 3A-2
plaques were scored). We assessed the ability of 3D-3ts to
rescue 3A-2 in the same experiments in which we examined
complementation between 2A-1 and 3A-2 (Table 2, experi-
ment 1). At both midcycle and late after infection, the 3A-2
titer was very similar to that obtained from virus stocks
made from cells coinfected with 2A-1 and 3A-2. Thus, it
appeared that 3D-3ts rescued 3A-2 as effectively as 2A-1 did.
We also tested the ability of 2B-201 to complement 3A-2
(Table 2, experiment 2). The problems described in the
preceding experiment did not occur because the titer of
2B-201 through most of the infectious cycle was much lower
than that of 3D-3 and because the plaques produced by
2B-201 on CV-1 monolayers at 39.5°C, like those of 3D-3ts,
were much smaller than 3A-2 plaques. Infected cells were
harvested at 6 and 7.5 h postinfection; the latter time was
chosen because it was the latest at which there was a
substantial (30- to 50-fold) difference in titer between 2B-201
and wild-type virus. For comparison, rescue of 3A-2 by 2A-1
was assessed in parallel. Rescue of 3A-2 by 2B-201 was
apparent at both time points; the titer of 3A-2, however, was
clearly severalfold less than that obtained in the mixed
infection with 2A-1. Hence, it appeared that 3A-2 was
rescued less effectively by 2B-201 than by the other mutants
described here.
Evidence that other cDNA-derived mutants cannot be com-
plemented. It was also possible to determine whether
2B-201, 3D-3, and 3NC-202 could be complemented by
exploiting their unique plaque phenotypes. We found that
2B-201 could not be rescued by any other mutant. HeLa
cells infected with both 2B-201 and 2A-1 and then incubated
at 37°C did not yield a higher 2B-201 titer than did cells
infected with 2B-201 alone (Fig. 4). Less than a twofold
enhancement of 2B-201 titer was observed when HeLa cells
were infected with 2B-201 and 3NC-202 and incubated at
39.5°C (Table 4). In this experiment, we determined 2B-201
titers by performing plaque assays at 39.5°C. The small
increase in 2B-201 titer may simply have been a consequence
of more rapid viral growth resulting from the use of a total
multiplicity of infection (MOI) of 10 in the double infections
(5 for each mutant) compared with 5 in the single infections.
Virus stocks were also made from CV-1 cells infected with
2B-201 and 3A-2 or with 2B-201 alone and then incubated at
32.5°C (Table 2, experiment 2). Despite an apparent fewfold
enhancement of the 2B-201 titer in the mixed stock at 6 h
postinfection, little enhancement was observed by 7.5 h.
3D-3 was also not complemented to a significant extent by
other mutants. To determine whether the lag in the devel-
opment of 3D-3 titer could be eliminated in a mixed infec-
tion, it was necessary to harvest cells relatively early after
infection. In one experiment, 3D-3 titers in virus stocks
prepared from CV-1 cells infected with 2A-1 and 3D-3,
3NC-202 and 3D-3, or 3D-3 alone and incubated at 39.5°C for
3 h were compared (Table 3, experiment 2). The 3D-3 titers
were determined by performing plaque assays at 39.5°C. The
twofold enhancement of the 3D-3 titer observed in both
mixed infections was not regarded as significant and again
may have merely been an MOI effect. In other experiments,
CV-1 cells were infected with both 3D-3 and the cold-
sensitive mutant 3A-2 and incubated at 32.5°C for 6 h. When
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plaque assays were performed at 32.5°C, there was no
significant difference in virus titer between the 3D-3 and
mixed stocks (data not shown).
We also tested the ability of the plaque size mutants to
rescue 3NC-202. In these experiments, 3NC-202 titers were
determined by plaque assay at 32.5°C. Stocks made from
CV-1 cells infected with both 3NC-202 and 2A-1 contained a
small amount of virus which yielded relatively large plaques
at low temperature, but the same number of plaques also
formed at high temperature (data not shown). These plaques
were produced primarily by variants which were presumably
either revertants or recombinants. Although relatively low,
the level of such variants was always higher than the level of
virus in 3NC-202 stocks. For example, at 4.75 h postinfec-
tion (Table 3, experiment 1), variants amounted to approxi-
mately 2 PFU per cell, a level which exceeded the titer of
virus in the 3NC-202 stock by 20-fold. As a consequence,
this methodology would not have been sensitive to a very
low level of 3NC-202 rescue. It is clear, however, that
substantial rescue of the mutant did not occur. It was more
difficult to test complementation of 3NC-202 by 3D-3 be-
cause the 3D-3 titer in mixed stocks was more than 2 orders
of magnitude greater than the titer of 3NC-202 in single-
infection stocks (Table 3, experiment 2). Anything less than
a several-hundredfold rescue of 3NC-202 would not have
been detected by plaque assay. A slightly higher titer was
observed in the mixed stock at 32.50C than at 39.50C.
Twenty-five plaques produced at low temperature were
picked, however, and none had a temperature-sensitive
phenotype. Finally, mixed infections were performed in
HeLa cells to test the ability of 2B-201 to rescue 3NC-202
(Table 4). The titer of virus obtained from the mixed stocks
was very similar at both high and low temperatures, and
plaques almost exclusively of the 2B-201 phenotype were
observed. Because of the large difference in titer of the two
mutants, however, only dramatic rescue of 3NC-202 could
have been observed.
DISCUSSION
We studied the rescue of five well-defined mutants of
poliovirus type I primarily by comparing virus yields in
single and mixed infections. In contrast to many results
obtained with unmapped mutants, we obtained strong evi-
dence that defects in at least two of the nonstructural
functions of the virus can be complemented to a very
significant extent. This finding implies that the nonstructural
portion of the polyprotein contains multiple complementa-
tion groups. The unambiguous rescue of mutants which
contain lesions in regions encoding proteins 2A and 3A
implies that the protein which mediates inhibition of host cell
translation and one of the components involved in RNA
synthesis can be provided in trans. The rescue of poliovirus
mutants which we observed is distinct from previous reports
of mutant rescue in two important respects. First, both 2A
and 3A mutants were rescued in mixed infections with all
other mutants which contain lesions in other parts of the
genome and which are not trans dominant, rather than in just
one particular mixed infection. Second, the titer of both
mutants was enhanced in mixed infections at a time when
significant accumulation of progeny virus was first detected,
not just at the end of a full cycle of growth. These observa-
tions help to support the notion that the rescue we observed
involved true genetic complementation, that is, compensa-
tion for defects by the diffusion of functional gene products,
and was not due to a nonspecific effect. Our studies are also
distinct from previous work in that we corroborated the
virus yield data with independent evidence of complemen-
tation. We correlated enhancement of virus titer with in-
creases in the synthesis of virus-specific macromolecules
and in the progression of the cytopathic effect. We also
found that mutant rescue correlated with a reduction in the
proportion of apparent revertants in virus stocks prepared
from mixed as compared with single infections. This obser-
vation suggests that complementation reduces the selective
pressure which favors variants that grow better than the
parental strain. Moreover, these studies describe the first
example of two-way rescue of poliovirus mutants.
In addition to demonstrating complementation of two
nonstructural mutants, we also found that two mutants
which are defective in RNA synthesis could not be comple-
mented to a significant extent by other mutants. Although a
low level of complementation cannot be completely ex-
cluded, the titer of a mutant which contains an insertion in
the 3'-untranslated region of the RNA was also not greatly
enhanced in mixed infections with other mutants.
Comparison of the rescue of 2A-1 and 3A-2. The titers of
both 2A-1 and 3A-2, which contain single amino acid inser-
tions in the 2A and 3A regions of the polyprotein, respec-
tively, could be increased greater than 50-fold in mixed
infections with other mutants. In both cases, the levels of
complementation observed both at midcycle and late after
infection were similar. Presumably, either diffusion of the
functional product was continuous or production of a small
amount of functional protein early after infection was suffi-
cient to effect rescue. There were two respects, however, in
which the complementation patterns of these two mutants
differed. First, the rescue of 2A-1 was more complete than
that of 3A-2. That is, the titer of 2A-1 which resulted from a
mixed infection was only a fewfold lower than that of
wild-type virus, whereas the titer of 3A-2 was approximately
10-fold lower. Second, although complementation of 2A-1
always brought the yield of that mutant to the same level
relative to wild-type virus, the degree of rescue of 3A-2 was
more variable.
A consideration of the functions impaired by the two
lesions suggests an explanation for these differences in
complementation pattern. Experiments with guanidine, an
inhibitor of viral replication, have shown that at an MOI of
10 or more, the small amount of protein produced by input
RNA is sufficient to mediate effective inhibition of host cell
translation (20). In addition, mutants such as 3A-2 and
3NC-202, which synthesize RNA in a highly temperature-
dependent manner, are capable of inhibiting host cell trans-
lation at the nonpermissive temperature in the absence of
significant viral protein synthesis (Fig. 3, lane 3; reference
24). Hence, the observation that effective rescue of 2A-1 is
relatively independent of the amount of protein or RNA
produced by the other mutant in mixed infections is consis-
tent with the notion that only small amounts of the transla-
tional inhibitor are required. This hypothesis is reinforced by
a report that a 3NC-202 cDNA-bearing cell line partially
complements the mutant under conditions in which the cells
produce too little viral protein to be easily detected by other
means (24; Sarnow and Baltimore, unpublished data). Fur-
thermore, effective rescue of 2A-1 by mutants such as
3NC-202 implies that the function which mediates inhibition
of host cell translation probably does not work by selectively
promoting virus-specific translation, since such a function
would almost certainly be required in higher amounts than
the rescuing mutant can provide.
By contrast to the mutation in 2A-1, the insertion in 3A-2
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disrupts a function involved in replication which may be
required in substantial amounts. This notion appears partic-
ularly attractive given that the lesion maps to a segment of
the polyprotein which is contained in precursors of VPg (4,
26), the short protein which is found at the 5' end of every
poliovirus RNA molecule, and therefore may affect a func-
tion associated with VPg. The extent of 3A-2 rescue in mixed
infections correlated with the amount of protein ordinarily
synthesized by the other mutant. The best complementation
was obtained with 3D-3ts, which normally produces wild-
type levels of protein, and 2A-1, which can synthesize high
levels of viral protein once host-specific translation is inhib-
ited. The least effective rescue was obtained with 2B-201, a
mutant that produces only a small fraction as much RNA and
protein as does wild-type virus. These data are consistent
with the notion that rescue of 3A-2 is at least in part
dependent on the level of virus-specific products synthesized
by the complementary mutant. What is more difficult to
explain is the observation that rescue of 3A-2 was never as
complete as rescue of 2A-1. It has been shown that
poliovirus can synthesize a normal amount of RNA even if
virus-specific protein synthesis is greatly depressed (6).
Hence, in mixed infections involving 3A-2 and, say, 3D-3ts,
the synthesis of the complementary gene product probably
far exceeded the theoretical amount required for full rescue
of the mutant. A possible explanation for the incomplete
rescue of 3A-2 is that the required gene product might not be
uniformly distributed, presumably because of a compart-
mentalization problem or because of hindrance of free
diffusion (see also below).
Lack of rescue of three nonstructural mutants. We were
unable to demonstrate significant rescue of three mutants
which contain replication defects. Although partial rescue of
one of these mutants, 3NC-202, is not totally excluded by the
data, it seems unlikely that a mutant which has a lesion in a
noncoding region of the genome could be rescued in trans.
One possible explanation for our inability to demonstrate
complementation of the 2B and 3D mutants is that the
insertions do not alter protein function but rather disrupt the
structure of the RNA and thereby create cis-acting defects.
This explanation is not likely, however, given that at least at
a gross level comparative sequence analysis does not yield
evidence of important RNA structures within the coding
region. The RNA sequence is clearly conserved among
different strains of poliovirus (28) and different picorna-
viruses (2, 14, 27) at the 5' and 3' ends of the genome, but
only the amino acid sequence appears to be conserved in the
coding region. The explanation that the mutations appear cis
acting because they affect cleavage of the polyprotein is also
unlikely because no gross alteration of the cleavage pattern
was observed in either 2B-201- or 3D-3-infected cells. A far
more likely explanation is that the defective functions in
2B-201 and 3D-3 simply cannot be supplied in trans. If this
explanation holds true, and if the insertions we introduced
do not alter functions which reside in distant parts of the
polyprotein, then the overall picture of complementation
presented here suggests that the trans-acting functions of the
virus do not reside in adjacent segments of the polyprotein
but rather are interspersed among cis-acting functions. Such
a suggestion is not incompatible with the notion that the
nonstructural portion of the polyprotein must fold as a single
unit for some segments to be functional. But it does imply
that removal of internal segments of the polyprotein can
occur without disruption of the other nonstructural func-
tions. Of course, the lack of complementation of 2B-201 and
3D-3 may not be related to polyprotein folding at all but
rather may be due to some phenomenon which results in the
effective compartmentalization of the defective proteins.
One hypothesis to explain the cis-acting behavior of these
mutations is that the RNA replicase is a complex of proteins
which uses the specific plus-strand molecule from which it
was translated as a template to synthesize a minus strand. If
proteins 2B and 3D are part of this complex, it would be
understandable why lesions that destroy their function are
not complementable even by mutant 2A-1, which should be
able to make the functional forms of all proteins downstream
from 2A (6). Given evidence that guanidine sensitivity is
poorly complemented (K. Kirkegaard and D. Baltimore,
unpublished data), protein 2C, to which this genetic marker
maps (21, 25), might also be a cis-active part of the complex.
Even protein 3A might be part of the complex initially, but
the complementation of 3A-2 by mutants containing lesions
in 2B and 3D argues that it must be reversibly bound,
whereas the other elements are effectively irreversibly
bound to the complex and the RNA.
Nature of the poliovirus genome. One implication of these
experiments is that the noncapsid region of the poliovirus
genome cannot be considered to consist of a single genetic
unit whereby all functions reside in a single posttranslation-
ally processed polypeptide. Our results show that at least
two of the segments of the polyprotein act as independent
genetic units. Perhaps part of the reason that the poliovirus
genome consists of a single polyprotein is that certain
segments must be produced as part of a larger precursor or
need to fold together into a complex to function properly.
But clearly this is not the only reason, because some
segments can function independently (although their folding
may be directed by other parts of the polyprotein). Presum-
ably, the virus has adopted a polyprotein genome in part
because of the efficiency of gene expression which such a
strategy affords.
This study establishes the minimum number of "cistrons"
in the nonstructural region at three. Many more well-defined
mutants will have to be constructed before a complete
complementation map of the virus can be derived. Such a
map may provide clues as to how the virus replicates its
genome and performs other functions and may also help to
explain why the virus uses a unique genetic strategy.
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